South Africa Today on MSN
Salarius Pharmaceuticals Regains Compliance with All Nasdaq Listing Requirements
“Salarius is now fully compliant with all Nasdaq listing requirements, marking another critical step in our planned merger with Decoy Therapeutics,” said Mark J. Rosenblum, acting CEO and CFO of ...
Tagraxofusp demonstrated a manageable safety profile but limited efficacy in CMML patients, with stable disease as the best ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results